Abstract
Peritonitis is a serious and common infection. Its pathogenesis and microbiology have been well defined. Such risk factors as age, site of infection, physiologic response of the patient, presence of organ dysfunction, and malnutrition may influence the outcome of this disease process. The presence of antibioticresistant organisms and delays in operative intervention are also associated with treatment failure and higher mortality. Surgeons have the greatest impact on this disease in their ability to control the source of infection and to administer proper antimicrobial therapy.
Similar content being viewed by others
References and Recommended Reading
Malangoni MA: Evaluation and management of tertiary peritonitis. Am Surg 2000, 66:157–161. This review outlines risk factors, differences in microbiology, and outcomes of treatment for tertiary peritonitis.
Krepel CJ, Gohr CM, Edmiston CE, Condon RE: Surgical sepsis: constancy of antibiotic susceptibility of causative organisms. Surgery 1995, 117:505–509. A 12-year review of the microbiology of patients with intra-abdominal infections. This study emphasizes the critical role of the microbiology laboratory in the recovery of bacterial species.
Merlino JI, Malangoni MA, Smith CM, Lange RL: Prospective randomized trials affect the outcomes of intraabdominal infection. Ann Surg 2001, 233:859–866. This study demonstrates why there are discrepancies between patients treated in prospective, randomized trials and those not involved in a clinical study. There are clearly differences in entry criteria, treatment, cure, and mortality.
Montravers P, Gauzit R, Muller C, et al.: Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996 23:486–494. Excellent study demonstrating the important contribution of antibiotic-resistant organisms to treatment failure and mortality.
Nathens AB, Rotstein OD, Marshall JC: Tertiary peritonitis: clinical features of a complex nosocomial infection. World J Surg 1998, 22:158–163.
Seiler CA, Brügger L, Forssmann U, et al.: Conservative surgical treatment of diffuse peritonitis. Surg 2000, 127:178–184. This study demonstrates that most patients with intra-abdominal infections can be managed successfully with a single operation. It is important to adhere to the principles espoused by the authors, who emphasize proper antibiotic use, physiologic support, and appropriate operative decision making.
Christou NV, Turgeon P, Wassef R, et al.: Management of intraabdominal infections: the case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group. Arch Surg 1996, 131:1193–1201.
Dunn DL, Barke RA, Knight NB, et al.: Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun 1985, 49:257–264. Comprehensive review of the role of leukocytes and lymphatic absorption in the clearance of bacteria from the peritoneal cavity.
Nelson JL, Alexander JW, Mao JX, et al.: Effect of pentoxifylline on survival and intestinal cytokine messenger RNA transcription in a rat model of ongoing peritoneal sepsis. Crit Care Med 1999, 27:113–119.
Riche FC, Cholley BP, Panis YH, et al.: Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis. Crit Care Med 2000 28:433–437.
Tang GJ, Huang SL, Yien HW, et al.: Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000, 28:2733–2736.
O’Keefe GE Hybki DL Munford RS: The G > A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. J Trauma 2002, 52:817–825.
vanSonnenberg E, Wittich GR, Goodacre BW, et al.: Percutaneous abscess drainage: update. World J Surg 2001, 25:362–369.
Malangoni MA, Shumate CR, Thomas HA, Richardson JD: Factors influencing the treatment of intra-abdominal abscesses. Am J Surg 1990, 159:167–171.
Cinat ME, Wilson SE, Din AM: Determinants for successful percutaneous image-guided drainage of intraabdominal abscess. Arch Surg 2002, 137:845–849.
Baril NB, Ralls PW, Wren SM, et al.: Does an infected peripancreatic fluid collection or abscess mandate operation? Ann Surg 2000, 231:361–367.
Stabile BE, Puccio E, vanSonnenberg E, Neff C: Preoperative percutaneous drainage of diverticular abscesses. Am J Surg 1990, 159:99–104.
Haaga JR, Nakamoto D, Stellato T, et al.: Intracavitary urokinase for enhancement of percutaneous abscess drainage: phase II trial. AJR Am J Roentgenol 2000, 174:1681–1685.
Kok KY, Yapp SK: Laparoscopic drainage of postoperative complicated intraabdominal abscesses. Surg Laparosc Endosc Percutan Tech 2003, 10:311–313.
Butler JA, Huang J, Wilson SE: Repeated laparotomy and postoperative intra-abdominal sepsis: an analysis of outcome predictors. Arch Surg 1987, 122:702–706.
Wacha H, Hau T, Dittmer R, Ohmann C: Risk factors associated with intraabdominal infections: a prospective multicenter study. Peritonitis Study Group. Langenbecks Arch Surg 1999, 384:24–32. This report analyzes the risk factors associated with the outcome of intra-abdominal infection in a large patient population studied at multiple European institutions.
Koperna T, Schulz F: Relaparotomy in peritonitis: prognosis and treatment of patients with persisting intraabdominal infection. World J Surg 2000 24:32–37. Report based on a large number of patients undergoing reoperation for peritonitis. The authors have long-standing interest in management of intra-abdominal infections.
Solomkin JS, Wilson SE, Christou NV, et al.: Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections. Ann Surg 2001, 233:79–87.
Wilson SE, Faulkner K, Biol C, Biol MI: Impact of anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections. Am Surg 1998, 64:402–407.
Solomkin JS, Yellin AE, Rotstein OD, et al., and the Protocol 017 Study Group: Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Ann Surg 2003, 237:235–245.
Cohn SM, Lipsett PA, Buchman TG, et al.: Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of intraabdominal infections. Ann Surg 2000 232:254–262.
Bosscha K, Reijnders K, Hulstaert PF, et al.: Prognostic scoring systems to predict outcome in peritonitis and intraabdominal sepsis. Br J Surg 1997, 84:1532–1534.
Christou NV, Barie PS, Dellinger EP, et al.: Surgical Infection Society intra-abdominal infection study: prospective evaluation of management techniques and outcome. Arch Surg 1993, 128:193–198.
Evans HL, Raymond DP, Pelletier SJ, et al.: Tertiary peritonitis (recurrent diffuse or localized disease) is not an independent predictor of mortality in surgical patients with intraabdominal infection. Surg Infect 2001, 2:255–265. This study demonstrates that the outcome from tertiary peritonitis is related to a number of identifiable risk factors, including age, increasing APACHE II score, underlying disease, and source of infection.
Pusajo JF, Bumaschny E, Doglio GR, et al.: Postoperative intraabdominal sepsis requiring reoperation: value of a predictive index. Arch Surg 1993, 128:218–222.
Billing A, Fröhlich D, Schildberg FW, and the Peritonitis Study Group: Prediction of outcome using the Mannheim Peritonitis Index in 2003 patients. Br J Surg 1994, 81:209–213.
Wickel DJ, Cheadle WG, Mercer-Jones MA, Garrison RN: Poor outcome from peritonitis is caused by disease acuity and organ failure not recurrent peritoneal infection. Ann Surg 1997, 225:744–756.
Khuri SF, Daley J, Henderson W, et al.: Risk adjustment of the postoperative mortality rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg 1997, 185:316–327.
Kollef MH: Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000, 31(Suppl 4):S131-S138.
Malangoni MA, Condon RE, Spiegel CA: Treatment of intraabdominal infections is appropriate with single agent or combination antibiotic therapy. Surg 1985, 98:648–655.
Sandven P, Qvist H, Skovlund E, Giercksky KE, for the NORGAS group and the Norwegian Yeast Study Group: Significance of Candida recovered from intraoperative specimens in patients with intraabdominal perforations. Crit Care Med 2002, 30:541–547.
Gloor B, Worni M, Büchler MW: Diffuse peritonitis. In Source Control: A Guide to the Management of Surgical Infections. Edited by Schein M, Marshall JC. Berlin: Springer; 2003:87–91.
Schein M, Marshall JC, eds: Source Control: A Guide to the Management of Surgical Infections. Berlin: Springer; 2003. An excellent resource for those interested in the treatment of surgical infections. The authors outline a number of important points about management of intra-abdominal infections.
Sawyer RG: Tertiary peritonitis. In Source Control: A Guide to the Management of Surgical Infections. Edited by Schein M, Marshall JC. Berlin: Springer; 2003:341–347.
Hau T, Ohmann C, Wolmershauser A, et al.: Planned relaparotomy vs relaparotomy on demand in the treatment of intraabdominal infections. The Peritonitis Study Group of the Surgical Infection Society-Europe. Arch Surg 1995, 130:1193–1196.
Hinsdale JG, Jaffe BM: Re-operation for intra-abdominal sepsis: indications and results in modern critical care setting. Ann Surg 1984, 199:31–36.
Steinberg D: On leaving the peritoneal cavity open in acute generalized suppurative peritonitis. Am J Surg 1979, 1376:216–220.
Schein M, Paladugtu R: Planned relaparotomies and laparostomy. In Source Control: A Guide to the Management of Surgical Infections. Edited by Schein M, Marshall JC. Berlin: Springer; 2003:412–423.
Platell C, Papadimitriou JM, Hall JC: The influence of lavage on peritonitis. J Am Coll Surg 2000, 191:672–680.
Mazuski JE, Sawyer RG, Nathens AB, et al.: The Surgical Infection Society guidelines on antimicrobial therapy for intraabdominal infections: an executive summary. Surg Infect 2002, 3:161–173. This article reviews the appropriate antibiotics available for use in intra-abdominal infections. It outlines choices based on the severity of peritonitis and has important information about duration of antibiotic administration.
Bailey JA, Virgo KS, DiPiro JT, et al.: Aminoglycosides for intraabdominal infection: equal to the challenge? Surg Infect 2002, 3:315–335.
Taylor E, Dev V, Shah D, et al.: Complicated appendicitis: is there a minimum intravenous antibiotic requirement? A prospective randomized trial. Am Surg 2000, 66:887–890.
Barie PS, Christou NV, Dellinger EP, et al.: Pathogenicity of the enterococcus in surgical infections. Ann Surg 1990, 212:155–159.
Burnett RJ, Haverstock DC, Dellinger EP, et al.: Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial. Surgery 1995, 118:716–721.
Scheingraber S, Kurz T, Dralle H: Short- and long-term outcome and health-related quality of life after severe peritonitis. World J Surg 2002, 26:667–671.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Malangoni, M.A. Current concepts in peritonitis. Curr Gastroenterol Rep 5, 295–301 (2003). https://doi.org/10.1007/s11894-003-0066-y
Issue Date:
DOI: https://doi.org/10.1007/s11894-003-0066-y